HillSignal

Eli Lilly

private
Total Raised
--
Contracts
--
Patents
--

AI Intelligence Briefcase

Synthesize all available public data, government contracts, patent filings, and funding rounds for Eli Lilly into a comprehensive strategic report.

Government Contracts & Awards

No recent government contracts or awards found.

Proprietary Tech & Patents

No recent patents found.

Form D Funding

No recent SEC Form D filings found.

Market Intelligence & News

Wire Jun 23, 2026

Eli Lilly, Space Command help lead Alabama to Silver Shovel Award

Wire Jun 23, 2026

Alabama earns Silver Shovel Award after Space Command, Eli Lilly investments

Wire Jun 23, 2026

Governor Ivey Announces Eli Lilly, Space Command and Other State Economic Growth Help Earn Alabama a Silver Shovel Award - Alabama Governor's Office (.gov)

Wire Jun 23, 2026

Eli Lilly, Space Command and other growth help earn Alabama a Silver Shovel Award

Yahoo Jun 19, 2026

The Next Wave of Medical AI Could Mint More Millionaires Than the First -- Here Are the Stocks to Own

AI's next winners in healthcare could be companies like Eli Lilly and Twist Bioscience.

Yahoo Jun 18, 2026

3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound

Led by Eli Lilly’s GLP-1 success, Humana’s expanding margins, and DexCom’s medtech growth, the healthcare sector is staging a major market rebound.

Yahoo Jun 17, 2026

Eli Lilly Stock's Trillion-Dollar Question

Management raised the bar, the stock rocketed higher, and now everyone is wondering if this is the new normal or just a sugar high.

Yahoo Jun 17, 2026

Everyone Is Watching Eli Lilly Stock's New Drugs. Here Is the Metric That Vanished

Management once made manufacturing its top priority; now that the topic has gone quiet, it reveals just how much the company's multi-billion-dollar bet has fundamentally changed.

SeekingAlpha Jun 17, 2026

Novo Nordisk: A Fallen Leader Trading At Fair Value, Not A Bargain

Novo Nordisk has lost GLP-1 leadership against Eli Lilly. Click here to read more about NVO stock and why it is a Hold.

Yahoo Jun 16, 2026

Can Retatrutide Extend Eli Lilly and Co (LLY)’s Lead in Weight Loss Market?

Eli Lilly and Co (NYSE:LLY) is one of billionaire Ken Fisher’s top high growth stock picks. In the past month, Lilly shares have gained more than 18%. The shares have soared almost 50% over the past year. On June 6, Eli Lilly and Co (NYSE:LLY) presented results from late-stage trials of its weight-loss drug candidate, […]

Factual Connections

Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.

Upgrade to Pro